Connect with us
Vytrus Biotech’s 2024 Sustainability Report highlights major progress in plant stem cell innovation, resource savings, and ESG efforts. Key achievements include award-winning product Baolift™, strong certifications,...
Pfizer Spain’s 2024 Impact Report highlights its leadership in clinical research, €54M R&D investment, four new treatments, and 113 trials across 13 areas. Marking Pfizer’s 175th...
Obesity, diabetes, and cardiovascular disease are increasingly common in the population. Brown adipose tissue plays a protective role against these prevalent diseases, as it burns calories...
In 2024, Europe and Spain advanced strategic biotechnology legislation, reinforcing biotech as key to economic growth and autonomy. Spain’s biotech sector grew, generating €13B in revenue...
Galicia has approved a €15.6 million investment to supply gene therapy for hemophilia B, becoming the first region in Spain to do so. The therapy, Etranacogene...
A BioSim study highlights biosimilars’ crucial role in reducing Spain’s healthcare spending, projecting €22.27 billion in savings from 2024–2030. Despite rising biologic drug costs, biosimilars ensure...
SpliceBio raised $135 million in a Series B round led by EQT Life Sciences and Sanofi Ventures, with support from major biotech investors. The funding will...
3A Biotech introduces Tocotyrosol and Bioprotec RT—natural, multifunctional ingredients enhancing food stability, safety, and health. Tocotyrosol offers antioxidant and health benefits, while Bioprotec RT provides antimicrobial...
María Río (Gilead) and Marina Pollán (ISCIII) formalized the 12th Gilead Biomedical Research Grants, Spain’s top pharma-sponsored R&D initiative. It supports HIV, oncology, and now PrEP...
Researchers developed a highly sensitive (99%) liquid biopsy blood test to detect HPV-related head and neck cancers. By identifying circulating tumor DNA post-surgery, it enables early...
 |
|
 |  |
 |
|